244 related articles for article (PubMed ID: 19702533)
1. The heme oxygenase/biliverdin reductase pathway in drug research and development.
Mancuso C; Barone E
Curr Drug Metab; 2009 Jul; 10(6):579-94. PubMed ID: 19702533
[TBL] [Abstract][Full Text] [Related]
2. The brain heme oxygenase/biliverdin reductase system as a target in drug research and development.
Mancuso C
Expert Opin Ther Targets; 2022 Apr; 26(4):361-374. PubMed ID: 35285395
[TBL] [Abstract][Full Text] [Related]
3. The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.
Barone E; Di Domenico F; Mancuso C; Butterfield DA
Neurobiol Dis; 2014 Feb; 62():144-59. PubMed ID: 24095978
[TBL] [Abstract][Full Text] [Related]
4. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.
Miralem T; Hu Z; Torno MD; Lelli KM; Maines MD
J Biol Chem; 2005 Apr; 280(17):17084-92. PubMed ID: 15741166
[TBL] [Abstract][Full Text] [Related]
5. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
[TBL] [Abstract][Full Text] [Related]
6. The heme oxygenase/biliverdin reductase system in skin cancers.
Arena V; Pennacchia I; Guerriero G; Mancuso C
J Biol Regul Homeost Agents; 2015; 29(1):259-64. PubMed ID: 25864768
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of the antioxidant enzymes biliverdin reductase and heme oxygenase-2 in human and pig gastric fundus.
Colpaert EE; Timmermans JP; Lefebvre RA
Free Radic Biol Med; 2002 Apr; 32(7):630-7. PubMed ID: 11909697
[TBL] [Abstract][Full Text] [Related]
8. The presence of heme-oxygenase and biliverdin reductase in human cranial ganglia indicates a role for carbon monoxide in neural transmission.
Uddman R; Tajti J; Sundler F; Cardell LO
Neuro Endocrinol Lett; 2004 Dec; 25(6):423-8. PubMed ID: 15665804
[TBL] [Abstract][Full Text] [Related]
9. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.
Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A
J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037
[TBL] [Abstract][Full Text] [Related]
10. The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction.
Ding B; Gibbs PE; Brookes PS; Maines MD
FASEB J; 2011 Jan; 25(1):301-13. PubMed ID: 20876213
[TBL] [Abstract][Full Text] [Related]
11. Biliverdin reductase is heat resistant and coexpressed with constitutive and heat shock forms of heme oxygenase in brain.
Ewing JF; Weber CM; Maines MD
J Neurochem; 1993 Sep; 61(3):1015-23. PubMed ID: 8360669
[TBL] [Abstract][Full Text] [Related]
12. Activation of heme oxygenase and consequent carbon monoxide formation inhibits the release of arginine vasopressin from rat hypothalamic explants. Molecular linkage between heme catabolism and neuroendocrine function.
Mancuso C; Kostoglou-Athanassiou I; Forsling ML; Grossman AB; Preziosi P; Navarra P; Minotti G
Brain Res Mol Brain Res; 1997 Oct; 50(1-2):267-76. PubMed ID: 9406943
[TBL] [Abstract][Full Text] [Related]
13. The heme oxygenase/biliverdin reductase system: a potential drug target in Alzheimers disease.
Mancuso C; Santangelo R; Calabrese V
J Biol Regul Homeost Agents; 2013; 27(2 Suppl):75-87. PubMed ID: 24813317
[TBL] [Abstract][Full Text] [Related]
14. Potential application of biliverdin reductase and its fragments to modulate insulin/IGF-1/MAPK/PI3-K signaling pathways in therapeutic settings.
Maines MD
Curr Drug Targets; 2010 Dec; 11(12):1586-94. PubMed ID: 20704544
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in the Understanding of the Reaction Chemistries of the Heme Catabolizing Enzymes HO and BVR Based on High Resolution Protein Structures.
Sugishima M; Wada K; Fukuyama K
Curr Med Chem; 2020; 27(21):3499-3518. PubMed ID: 30556496
[TBL] [Abstract][Full Text] [Related]
16. Heme oxygenase-1 as a protective gene.
Bach FH
Wien Klin Wochenschr; 2002; 114 Suppl 4():1-3. PubMed ID: 15499991
[TBL] [Abstract][Full Text] [Related]
17. Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes.
Rochette L; Zeller M; Cottin Y; Vergely C
Trends Endocrinol Metab; 2018 Feb; 29(2):74-85. PubMed ID: 29249571
[TBL] [Abstract][Full Text] [Related]
18. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells.
Kim HP; Wang X; Galbiati F; Ryter SW; Choi AM
FASEB J; 2004 Jul; 18(10):1080-9. PubMed ID: 15226268
[TBL] [Abstract][Full Text] [Related]
19. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
Reed JR; Huber WJ; Backes WL
Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
[TBL] [Abstract][Full Text] [Related]
20. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.
Maghzal GJ; Leck MC; Collinson E; Li C; Stocker R
J Biol Chem; 2009 Oct; 284(43):29251-9. PubMed ID: 19690164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
